v3.25.1
Net Loss Per Common Share
3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Net Loss Per Common Share

Note 11—Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Since the Company had a net loss in all periods presented, basic and diluted net loss per common share are the same.

In August 2023, the Company issued the liability-classified 2023 Pre-Funded Warrants with a nominal exercise price of $0.001 per share, which were subsequently reclassified into equity in November 2023 after conditions for exercise were met. In June 2024, the Company issued the June 2024 Pre-Funded Warrants with a nominal exercise price of $0.001 per share, which were subsequently reclassified into equity in November 2023 after conditions for exercise were met. See Note 10 for more information. In accordance with ASC 260, Earnings Per Share, shares issuable for little to no cash consideration should be included in the number of outstanding shares used to calculate basic loss per share as long as all conditions necessary for exercise are met. The 2023 Pre-Funded Warrants and the June 2024 Pre-Funded Warrants are therefore included as outstanding shares as of March 31, 2025 to calculate the weighted average number of shares outstanding to calculate basic loss per share.

The following table represents the calculation of basic and diluted net loss per common share for the three months ended March 31, 2025 and 2024, respectively (in thousands, except share and per share data):

 

 

 

For the Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Net loss

 

$

(21,529

)

 

$

(24,061

)

Weighted-average shares of common stock outstanding used to compute net loss per common share, basic and diluted

 

 

269,306,331

 

 

 

231,249,344

 

Net loss per common share, basic and diluted

 

$

(0.08

)

 

$

(0.10

)

 

The following common stock equivalents outstanding as of March 31, 2025 and 2024 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti‑dilutive:

 

 

 

March 31,
2025

 

 

March 31,
2024

 

Unvested RSUs

 

 

6,241,566

 

 

 

4,657,971

 

Stock options

 

 

24,326,199

 

 

 

15,162,463

 

SSI Warrants

 

 

316,667

 

 

 

316,667

 

Total

 

 

30,884,432

 

 

 

20,137,101